However, their clinical application requires rigorous evaluation of therapeutic efficacy, comprehensive safety profiling, and well-defined patient selection criteria
This concern is real but often overstated, particularly in people who are insulin sensitive or adapting to fat burning, and it becomes secondary to the muscle preservation imperative when semaglutide is involved
Foster Goss, DO, MMSc, FACEP, an adjunct professor and site principal investigator for this study at the University of Colorado Anschutz Department of Emergency Medicine, co-authored a research letter on the study, published recently in JAMA Health Forum
Patients with a history of gastrointestinal conditions such as acid reflux, irritable bowel syndrome, or gastroparesis should be especially cautious when starting GLP-1 medications
Escalate by one step
NEW - Blue Shield will launch three PPO Savings Plans offering expanded weight loss drug coverage in 2027: Full PPO Savings Embedded Deductible 3400 100% with Enhanced+ Rx Full PPO Savings Two-Tier Embedded Deductible 1700/3400/3400 90/60 with Enhanced+ Rx NOTE: Weight loss drugs under these plans are covered with prior authorization for BMI 30 or 27 with certain weight-related conditions, lowering the requirement from the previous BMI of 40
